Past Podcast Episodes

Over the past several weeks, the United States has been forced to re-visit, re-examine, and reconsider its own history of racial inequality. This difficult but necessary national conversation has been driven by instances of racial injustice that have their origins in much broader systemic or institutional racism. Our conversations on RealTalk MS typically focus on multiple sclerosis research and multiple sclerosis care. So how does the subject of racial inequality find its way onto today's episode?

My guest is Dr. Jackie Bhattarai, a clinical psychologist and Assistant Professor of Physical Medicine and Rehabilitation at Johns Hopkins School of Medicine. Dr. Bhattarai's research is focused on identifying and understanding the causes of racial disparities in multiple sclerosis care. I think you'll find our conversation thought-provoking, maybe surprising and, I hope, concerning.

We're also inviting you to this week's International Progressive MS Alliance global webcast when an international panel of MS experts will share the progress being made to speed the development of life-changing treatments for progressive MS. Our experts will also update us on the experiences of people living with MS who have contracted COVID-19, and how people with MS can minimize their risks during the pandemic.

We'll tell you about a new National Institutes of Health grant aimed at determining the reliability of a proposed biomarker for MS. And we'll share the sobering results of a new study about MS and depression.

We have a lot to talk about! Are you ready for RealTalk MS??!

Don't miss the International Progressive MS Alliance Webcast 1:30

Cleveland Clinic receives NIH grant to study MS diagnostic biomarker 3:58

Depression is 2-3 times more likely in MS patients 6:23

My Interview with Dr. Jackie Bhattarai 9:21

Share this episode 26:35

Please Support the National MS Society COVID-19 Response Fund 26:54

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/147

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

National MS Society COVID-19 Response Fund

International Progressive MS Alliance Webcast Registration

STUDY: Incident Depression in Patients Diagnosed with Multiple Sclerosis: A Multi-Database Study

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 147
Hosted By: Jon Strum
Guests: Dr. Jackie Bhattarai

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy

Integrative medicine combines evidence-based alternative medicine with conventional medicine. My guest is Dr. Allen Bowling, an internationally renowned neurologist who specializes in integrative medicine for MS.

When it comes to care and treatment for MS, Dr. Bowling has published over 100 articles in clinical and basic science journals. He's been involved in research related to nutrition, dietary supplements, and other non-pharmacologic therapies for the past 30 years. And our conversation covers CBD and other cannabis products as potential treatments for MS symptoms, we'll talk about diet and exercise, over the counter supplements, maintaining your emotional health, and lots more.

An international committee of distinguished experts has just issued an important clarification in the terminology used to describe the status of a person with MS (including “active” secondary progressive, “worsening”, and “progression”). We'll tell you all about this clarification and explain how it affects everything from recruiting for clinical trials to providing access to current MS disease-modifying therapies.

We're also talking about a new Cleveland Clinic study that shows that neurological function deteriorates more quickly in depressed MS patients. We'll tell you about a study that underscores the importance of screening and treating people living with MS for anxiety along with depression. And you'll hear about a new web-based tool designed to help manage your emotional wellness.

We have a lot to talk about! Are you ready for RealTalk MS??!

Expert panel clarifies terms used in describing MS disease status 2:33

COVID-19 in people with MS being treated with Ocrevus 7:45

Study shows neurological function deteriorates quicker in depressed MS patients 10:44

Anxiety & Depression in MS — Study measures impact on quality of life 13:34

MS Trust & Biogen launch ACT MySelf web-based emotional wellness tool 16:06

My Interview with Dr. Allen Bowling 19:19

Share this episode 43:18

Please Support the National MS Society COVID-19 Response Fund 43:41

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/146

ADD YOUR VOICE TO THE CONVERSATION

Email: jon@realtalkms.com

Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

National MS Society COVID-19 Response Fund

Dr. Allen Bowling: Neurology Care

The 2013 Clinical Course Descriptors for Multiple Sclerosis: A Clarification

COVID-19 in Persons with Multiple Sclerosis Treated with Ocrelizumab — A Pharmacovigilance Case Series

STUDY: Depression in MS is Associated with Worsening Neuroperformance, Relapses, and New Brain Lesions

STUDY: Anxiety and Depression in Multiple Sclerosis (MS): Antecedents, Consequences, and Differential Impact on Well-Being and Quality of Life

ACT MySelf

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android